Table of Contents Table of Contents
Previous Page  72 / 127 Next Page
Information
Show Menu
Previous Page 72 / 127 Next Page
Page Background

70

A interface vítreo-retiniana

AVM, TVM e BM

25 Perguntas e respostas

REFERÊNCIAS

1.

Weber-Krause B, Eckardt U. [Incidence of poste-

rior vitreous detachment in eyes with and without

age-related macular degeneration. An ultrasonic

study]. Ophthalmologe 1996;93(6):660-5.

2.

Jackson TL, Nicod E, Angelis A, Grimaccia F,

Prevost AT, Simpson AR et al. Vitreous attach-

ment in age-related macular degeneration, dia-

betic macular edema, and retinal vein occlusion:

a systematic review and metaanalysis. Retina

2013;33(6):1099-108.

3.

Mojana F, Cheng L, Bartsch DU, Silva GA, Kozak

I, Nigam N et al. The role of abnormal vitreomacu-

lar adhesion in age-related macular degeneration:

spectral optical coherence tomography and surgi-

cal results. Am J Ophthalmol 2008;146(2):218-27.

4.

Schulze S, Hoerle S, Mennel S, Kroll P. Vitreomacu-

lar traction and exudative age-related macular de-

generation. Acta Ophthalmol 2008;86(5):470-81.

5.

Robison CD, Krebs I, Binder S, Barbazetto IA, Kot-

solis AI, Yannuzzi LA et al. Vitreomacular adhesion

in active and end-stage age-related macular degen-

eration. Am J Ophthalmol 2009;148(1):79-82.e2.

6.

Waldstein SM, Sponer U, Simader C, Sacu

S, Schmidt-Erfurth U. Influence of vitreo-

macular adhesion on the development of

exudative age-related macular degeneration:

4-year results of a longitudinal study. Retina

2012;32(3):424-33.

7.

Lee SJ, Koh HJ. Effects of vitreomacular adhe-

sion on anti-vascular endothelial growth factor

treatment for exudative age-related macular de-

generation. Ophthalmology 2011;118(1):101-10.

8.

Nomura Y, Ueta T, Iriyama A, Inoue Y, Obata R,

Tamaki Y et al. Vitreomacular interface in typical

exudative age-related macular degeneration and

polypoidal choroidal vasculopathy. Ophthalmol-

ogy 2011;118(5):853-9.

9.

Krebs I, Glittenberg F, Zeiler F, Binder S. Spectral

domain optical coherence tomography for higher

precision in the evaluation of vitreoretinal adhe-

sions in exudative age-related macular degenera-

tion. Br J Ophthalmol 2011;95(10):1415-8.

10.

Lee SJ, Lee CS, Koh HJ. Posterior vitreomacu-

lar adhesion and risk of exudative age-related

macular degeneration: paired eye study. Am J

Ophthalmol 2009;147(4):621-6.

11.

Üney GÖ, Ünlü N, Acar MA, Hazirolan D, Altipar-

mak UE, Yalniz-Akkaya Z et al. Role of poste-

rior vitreous detachment on outcome of anti-

vascular endothelial growth factor treatment in

age-related macular degeneration. Retina

2014;34(1):32-7.

Figura 4.

Após 2 anos de tratamento e 22

injecções intra-vítreas o doente

mantinha liquido subretiniano

persistente (A). Após a vitrectomia

o doente passou a responder

ao tratamento, apresentando

retina seca (B) e nos 18 meses

subsequentes de seguimento

apenas necessitou de 3 injecções

intra-vítreas de anti-VEGF.

A

B